Posts

Showing posts with the label nuvama institutional equities

tata motors: Stocks to buy today: Nuvama maintains reduce rating on Tata Motors; MS sees over 20% upside in Aditya Birla Capital

Image
[hfe_template id='11223'] [ad_1] Brokerage firms offer varied perspectives on select stocks. Morgan Stanley is optimistic about Aditya Birla Capital, citing improvements across business segments and re-rating potential. Synopsis Brokerage firms provide insights on select stocks. Morgan Stanley is optimistic about Aditya Birla Capital, citing improvements across business segments. Nuvama maintains a Buy rating on Jubilant Ingrevia, highlighting solid margins. However, Nuvama is cautious on Tata Motors, reducing its target price due to muted growth projections. These recommendations offer a mixed outlook for investors. Brokerage firms have shared their latest views on select stocks, offering a mix of bullish and cautious takes for the next 12 months.Morgan Stanley remains upbeat on Aditya Birla Capital, citing broad-based improvements across business segments and potential for re-rating.Meanwhile, Nuvama Institutional Equities has reaffirmed a Buy on Jubilant Ingrevia, hig...

Nuvama sees Afcons Infra in a ‘league of its own’, initiates coverage with Rs 535 target price

Image
[hfe_template id='11223'] [ad_1] Domestic brokerage firm Nuvama Institutional Equities has initiated coverage on Afcons Infrastructure Ltd (AIL) with a ‘buy’ rating and a target price of Rs 535, as it believes that the company is ‘in a league of its own’. The target price given by the brokerage firm implies a 23% upside potential from current levels. The brokerage firm highlights AIL’s combination of growth and stability, strong financial management, and robust order book as key drivers for its positive outlook. Consistent growth in a cyclical industry Despite operating in an inherently cyclical sector, Afcons has been among “the handful of contractors that have been able to deliver steady growth over a long period of time.” The company’s order book and order intake increased at a CAGR of 17–18% over FY06–9MFY25, while revenue and PAT clocked CAGRs of 18% and 29%, respectively, over FY06–24. Nuvama believes this momentum will continue, projecting EBITDA and PAT to compou...